{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:41:01Z","timestamp":1789940461686,"version":"4.0.1"},"reference-count":0,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[1995,4,1]],"date-time":"1995-04-01T00:00:00Z","timestamp":796694400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[1995,4]]},"abstract":"<jats:p>Tumaco, Colombia, is an area with elevated rates of tropical spastic paraparesis\/human T-cell leukemia virus type I (HTLV-I)-associated myelopathy (TSP\/HAM). We have identified a mutation in nucleotide 7959 of the tax gene of 14 Tumaco HTLV-I isolates (14 positive of 14 tested) that was present in 5 of 14 (35%) TSP\/HAM patients from Japan and in 8 of 11 (72%) TSP\/HAM patients from other geographic locations. In contrast, this mutation was found in only 2 of 21 (9.5%) HTLV-I-infected subjects outside of Tumaco who did not have TSP\/HAM. tax clones with nucleotide mutations including one at nucleotide 7959 showed a greater ability to transactivate the HTLV-I U3 promoter. However, this effect was not observed when two clones that differed only in nucleotide 7959 were compared. These results suggest that HTLV-I-infected individuals carrying isolates with this tax mutation are at higher risk for developing TSP\/HAM.<\/jats:p>","DOI":"10.1128\/jvi.69.4.2611-2616.1995","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T21:29:58Z","timestamp":1578346198000},"page":"2611-2616","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":29,"title":["Tax mutation associated with tropical spastic paraparesis\/human T-cell leukemia virus type I-associated myelopathy"],"prefix":"10.1128","volume":"69","author":[{"given":"B","family":"Renjifo","sequence":"first","affiliation":[{"name":"Department of Cancer Biology, Harvard School of Public Health, Boston, Massachusetts 02115."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Borrero","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Harvard School of Public Health, Boston, Massachusetts 02115."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Essex","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Harvard School of Public Health, Boston, Massachusetts 02115."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.69.4.2611-2616.1995","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jvi.69.4.2611-2616.1995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T13:14:06Z","timestamp":1646486046000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jvi.69.4.2611-2616.1995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,4]]}},"alternative-id":["10.1128\/jvi.69.4.2611-2616.1995"],"URL":"https:\/\/doi.org\/10.1128\/jvi.69.4.2611-2616.1995","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,4]]},"assertion":[{"value":"1995-04-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}